{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:38Z","timestamp":1707525398385},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,24]]},"DOI":"10.7759\/cureus.47570","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T13:15:24Z","timestamp":1698153324000},"source":"Crossref","is-referenced-by-count":1,"title":["The Burden of Heart Failure and Its Impact on Mortality and Outcomes in Hospitalized Multiple Myeloma Patients: A Nationwide Study"],"prefix":"10.7759","author":[{"given":"Saad","family":"Javaid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Frasier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammad J","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Del Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Multiple myeloma: from diagnosis to treatment","volume":"42","author":"Eslick R","year":"2013","unstructured":"Eslick R, Talaulikar D. Multiple myeloma: from diagnosis to treatment. Aust Fam Physician. 2013, 42:684-8.","journal-title":"Aust Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui AL","year":"2011","unstructured":"Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011, 8:30-41. 10.1038\/nrcardio.2010.165","journal-title":"Nat Rev Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14779072.2017.1409114","article-title":"Cardiovascular complications of multiple myeloma in the elderly","volume":"15","author":"Mathur P","year":"2017","unstructured":"Mathur P, Thanendrarajan S, Paydak H, et al.. Cardiovascular complications of multiple myeloma in the elderly. Expert Rev Cardiovasc Ther. 2017, 15:933-43. 10.1080\/14779072.2017.1409114","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"Kyle RA","year":"2008","unstructured":"Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008, 111:2962-72. 10.1182\/blood-2007-10-078022","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0784-4","article-title":"Cardiovascular complications associated with multiple myeloma therapies: incidence, pathophysiology, and management","volume":"21","author":"Patel VG","year":"2019","unstructured":"Patel VG, Cornell RF. Cardiovascular complications associated with multiple myeloma therapies: incidence, pathophysiology, and management. Curr Oncol Rep. 2019, 21:29. 10.1007\/s11912-019-0784-4","journal-title":"Curr Oncol Rep"},{"key":"ref6","unstructured":"NIS overview. (2022). Accessed. April 4, 2022: https:\/\/www.hcup-us.ahrq.gov\/nisoverview.jsp."},{"key":"ref7","unstructured":"International Classification of Diseases (ICD). (2022). Accessed. April 9, 2022: http:\/\/www.who.int\/standards\/classifications\/classification-of-diseases."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-022-02006-1","article-title":"Adaptation and validation of a coding algorithm for the Charlson Comorbidity Index in administrative claims data using the SNOMED CT standardized vocabulary","volume":"22","author":"Fortin SP","year":"2022","unstructured":"Fortin SP, Reps J, Ryan P. Adaptation and validation of a coding algorithm for the Charlson Comorbidity Index in administrative claims data using the SNOMED CT standardized vocabulary. BMC Med Inform Decis Mak. 2022, 22:261. 10.1186\/s12911-022-02006-1","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-019-0183-y","article-title":"Management of cardiovascular risk in patients with multiple myeloma","volume":"9","author":"Plummer C","year":"2019","unstructured":"Plummer C, Driessen C, Szabo Z, Mateos MV. Management of cardiovascular risk in patients with multiple myeloma. Blood Cancer J. 2019, 9:26. 10.1038\/s41408-019-0183-y","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2984","article-title":"Patient mortality following new-onset heart failure stratified by cancer type and status [IN PRESS]","author":"Nouhravesh N","year":"2023","unstructured":"Nouhravesh N, Strange JE, Holt A, et al.. Patient mortality following new-onset heart failure stratified by cancer type and status [IN PRESS]. Eur J Heart Fail. 2023, 10.1002\/ejhf.2984","journal-title":"Eur J Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuad072","article-title":"Characteristics, management and outcomes of active cancer patients with cardiogenic shock [IN PRESS]","author":"Merdji H","year":"2023","unstructured":"Merdji H, Gantzer J, Bonello L, et al.. Characteristics, management and outcomes of active cancer patients with cardiogenic shock [IN PRESS]. Eur Heart J Acute Cardiovasc Care. 2023, 10.1093\/ehjacc\/zuad072","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi OK","year":"2018","unstructured":"Siddiqi OK, Ruberg FL. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Trends Cardiovasc Med. 2018, 28:10-21. 10.1016\/j.tcm.2017.07.004","journal-title":"Trends Cardiovasc Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030610","article-title":"High output heart failure in multiple myeloma: pathogenetic considerations","volume":"14","author":"Carlisi M","year":"2022","unstructured":"Carlisi M, Mancuso S, Lo Presti R, Siragusa S, Caimi G. High output heart failure in multiple myeloma: pathogenetic considerations. Cancers (Basel). 2022, 14:610. 10.3390\/cancers14030610","journal-title":"Cancers (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2005.01.012","article-title":"The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study","volume":"7","author":"Calvert MJ","year":"2005","unstructured":"Calvert MJ, Freemantle N, Cleland JG. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail. 2005, 7:243-51. 10.1016\/j.ejheart.2005.01.012","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese G","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023, 118:3272-87. 10.1093\/cvr\/cvac013","journal-title":"Cardiovasc Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2833","article-title":"Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF","volume":"25","author":"Farmakis D","year":"2023","unstructured":"Farmakis D, Tromp J, Marinaki S, et al.. Impact of left ventricular ejection fraction phenotypes on healthcare resource utilization in hospitalized heart failure: a secondary analysis of REPORT-HF. Eur J Heart Fail. 2023, 25:818-28. 10.1002\/ejhf.2833","journal-title":"Eur J Heart Fail"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12450","article-title":"Health care utilization and mortality associated with heart failure-related admissions among cancer patients","volume":"6","author":"Guha A","year":"2019","unstructured":"Guha A, Dey AK, Armanious M, et al.. Health care utilization and mortality associated with heart failure-related admissions among cancer patients. ESC Heart Fail. 2019, 6:733-46. 10.1002\/ehf2.12450","journal-title":"ESC Heart Fail"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2010.71.5.47907","article-title":"Acute kidney injury in patients with decompensated heart failure","volume":"71","author":"Borman NL","year":"2010","unstructured":"Borman NL, Kalra PA, Kalra PR. Acute kidney injury in patients with decompensated heart failure. Br J Hosp Med (Lond). 2010, 71:269-75. 10.12968\/hmed.2010.71.5.47907","journal-title":"Br J Hosp Med (Lond)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.11.010","article-title":"Management of acute kidney injury in symptomatic multiple myeloma","volume":"99","author":"Bridoux F","year":"2021","unstructured":"Bridoux F, Leung N, Belmouaz M, Royal V, Ronco P, Nasr SH, Fermand JP. Management of acute kidney injury in symptomatic multiple myeloma. Kidney Int. 2021, 99:570-80. 10.1016\/j.kint.2020.11.010","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.029397","article-title":"Acute respiratory distress syndrome due to pulmonary involvement by neoplastic plasma cells in multiple myeloma","volume":"61","author":"Marmor DB","year":"2006","unstructured":"Marmor DB, Farber JL, Gottlieb JE. Acute respiratory distress syndrome due to pulmonary involvement by neoplastic plasma cells in multiple myeloma. Thorax. 2006, 61:455-6. 10.1136\/thx.2004.029397","journal-title":"Thorax"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/10499091211051667","article-title":"Trends, sociodemographic and hospital-level factors associated with palliative care utilization among multiple myeloma patients using the national inpatient sample (2016-2018)","volume":"39","author":"Jackson I","year":"2022","unstructured":"Jackson I, Jackson N, Etuk A. Trends, sociodemographic and hospital-level factors associated with palliative care utilization among multiple myeloma patients using the national inpatient sample (2016-2018). Am J Hosp Palliat Care. 2022, 39:888-94. 10.1177\/10499091211051667","journal-title":"Am J Hosp Palliat Care"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08079-x","article-title":"Hospitalization at the end of life in patients with multiple myeloma","volume":"21","author":"Abbasi S","year":"2021","unstructured":"Abbasi S, Roller J, Abdallah AO, Shune L, McClune B, Sborov D, Mohyuddin GR. Hospitalization at the end of life in patients with multiple myeloma. BMC Cancer. 2021, 21:339. 10.1186\/s12885-021-08079-x","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/173784-the-burden-of-heart-failure-and-its-impact-on-mortality-and-outcomes-in-hospitalized-multiple-myeloma-patients-a-nationwide-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:31Z","timestamp":1707509311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/173784-the-burden-of-heart-failure-and-its-impact-on-mortality-and-outcomes-in-hospitalized-multiple-myeloma-patients-a-nationwide-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.47570","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,24]]}}}